MRK ▲ +0.4% - Merck & Co., Inc.
$MRK - Ifinatamab Deruxtecan Biologics License Application for Certain Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer Voluntarily Withdrawn
25-SEP-2026 04:40 PM ET
Share this post
More filings for $MRK
MRK ▼ -0.4% - Merck & Co., Inc.Oct 13, 2026MRK ▲ +2.8% - Merck & Co., Inc.Oct 10, 2026MRK ▲ +0.3% - Merck & Co., Inc.Sep 30, 2026MRK ▲ +0.3% - Merck & Co., Inc.Sep 30, 2026MRK ▲ +0.1% - Merck & Co., Inc.Sep 28, 2026MRK ▲ +0.2% - Merck & Co., Inc.Sep 22, 2026
View full $MRK filing history →💬 Comments
Loading comments…
Leave a comment